While increasingly large reference panels for genome-wide imputation have been recently made available, the degree to which imputation accuracy can be enhanced by population-specific reference panels remains an open question. Here, we sequenced at full-depth (≥ 30×), across two platforms (Illumina X Ten and Complete Genomics, Inc.), a moderately large (n = 738) cohort of samples drawn from the Ashkenazi Jewish population. We developed a series of quality control steps to optimize sensitivity, specificity, and comprehensiveness of variant calls in the reference panel, and then tested the accuracy of imputation against target cohorts drawn from the same population. Quality control (QC) thresholds for the Illumina X Ten platform were identified that permitted highly accurate calling of single nucleotide variants across 94% of the genome. QC procedures also identified numerous regions that are poorly mapped using current reference or alternate assemblies. After stringent QC, the population-specific reference panel produced more accurate and comprehensive imputation results relative to publicly available, large cosmopolitan reference panels, especially in the range of rare variants that may be most critical to further progress in mapping of complex phenotypes. The population-specific reference panel also permitted enhanced filtering of clinically irrelevant variants from personal genomes.
Introduction
While genome-wide association studies (GWAS) have traditionally focused on the role of common genetic variation in common disease, it is increasingly acknowledged that rare genetic variation also significantly influences complex phenotypes (Kiezun et al. 2012) . The cost of sequencing to identify rare variation has declined dramatically in recent years; nevertheless, exome sequencing remains an order of magnitude higher in price compared to common SNP arrays, and high-depth whole-genome sequencing is even more expensive. Consequently, imputation has emerged as a popular approach that enables the examination of rare variants in the context of large-scale association studies in which subjects have been genotyped on conventional SNP arrays (Hoffman and Witte 2015) .
The accuracy and comprehensiveness of imputation depends on several factors, such as the size of the reference panel employed and the ancestry of its members relative to the target panel. Considerable effort has recently been devoted to generating increasingly large reference panels, usually involving cohorts sequenced at low-moderate (~ 4 to 10×) depth. Ancestry of these cohorts ranges from sampling across the global human population (e.g., 1000 Genomes Project Consortium 2015 to focusing on individuals from a particular population of origin such as the UK10K project ( UK10K Consortium 2015) and the Genome of the Netherlands Consortium (Genome of the Netherlands Consortium 2014). Attempts to characterize the trade-offs between breadth and depth of ancestry sampling have led to conflicting conclusions Deelen et al. 2014) , Todd Lencz and Jin Yu contributed equally.
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although recent studies have consistently demonstrated enhanced accuracy of imputation for a given subpopulation when cosmopolitan reference panels such as 1000 Genomes are supplemented with data from population-specific reference panels (Wong et al. 2013; Pistis et al. 2015) . Similar results have been obtained in non-human species (Ventura et al. 2014) , with increasing diversity of the reference panel especially beneficial for imputation of low-frequency alleles (Druet et al. 2014) .
Most recently, the Haplotype Reference Consortium (McCarthy et al. 2016) has assembled data from multiple worldwide studies involving a total of ~ 32,000 sequenced participants. While this resource has been demonstrated to enhance accuracy of imputation and, consequently, power of GWAS compared to the 1000 Genomes reference panel (Iglesias et al. 2017) , it remains to be seen whether accuracy can be further enhanced by population-specific sequencing.
In the present study, we tested whether imputation of rare variants could be improved by the addition of a moderately large (n = 738), population-specific reference panel sequenced to full depth (≥ 30×). Specifically, we examined the Ashkenazi Jewish (AJ) population, which possesses unique characteristics, making it a compelling model for genetic investigation. While comprising ~ 10 7 individuals today, the AJ population descends from a founding bottleneck that is very narrow, with effective population size likely less than 1000 chromosomes. This bottleneck is also very recent, having taken place only ~ 30 generations before present (Palamara et al. 2012; Carmi et al. 2014) .
Development of enhanced referenced panels of sequenced individuals from a population also has relevance to the clinical setting, in which any personal genome includes many variants of unknown significance (Dewey et al. 2014) . Such panels permit the identification of alleles that segregate in a population at appreciable frequencies, which otherwise might be erroneously interpreted as unique to a given patient with an unusual phenotype (MacArthur et al. 2014) . As with imputation, recent studies with increasingly large reference panels suggest that such distinctions remain problematic due to the extremely diffuse nature of human genetic diversity , and can be especially difficult in founder and endogamous populations with unique demographic histories (Ankala et al. 2015) . The development of such resources is especially urgent given the recent observation that many previously-identified risk genes and variants may be erroneously classified due to lack of sufficiently powerful reference databases (Whiffin et al. 2017; Walsh et al. 2017) .
Thus, the present study is intended as a resource for the research and clinical genomics communities to enhance the interpretability of both large-scale genotype datasets and individual-level sequence data. In creating our highdepth, population-specific reference panel, we first found it necessary to refine a set of practical quality control (QC) guidelines for high-depth whole-genome sequencing. These QC procedures are described in the "Materials and methods" below, and QC-relevant observations are described in the initial portion of the "Results".
Materials and methods

Cohort description
Samples sequenced using CGI (n = 168) included control samples (n = 128) described previously (Carmi et al. 2014) as well as schizophrenia cases (n = 40). Illumina samples (n = 574) included samples described previously from multiple case-control cohorts described in Supplementary  Table 1 . By design, these samples included some overlapping CGI controls (n = 5) and CGI schizophrenia cases (n = 4). All samples had been self-reported to be Ashkenazi Jewish, and also verified as Ashkenazi Jewish by principal components analysis of previously collected SNP array data as described in our prior publications (Atzmon et al. 2010; Guha et al. 2012) . Informed consent was obtained in accordance with institutional policies and the study was approved by the corresponding institutional review boards.
Sequencing and analysis pipeline
For samples sequenced on the Illumina platform, genomic DNA was isolated from whole blood and was quantified using PicoGreen on a Spectramax fluorometer (Molecular Devices) or Qubit (Life Technologies), and integrity assessed using the Fragment Analyzer (Advanced Analytical). A separate aliquot was removed and used for SNP array genotyping using the HumanExome-12 v1.2-A (Illumina) chip. Sequencing libraries were prepared using the Illumina TruSeq Nano DNA kit, with 100 ng input gDNA following manufacturer recommendations. Briefly, DNA was first sheared on a Covaris sonicator, followed by end-repair of the fragmented molecules and bead based size selection. Size selected molecules were then A-tailed followed by ligation of sequencing adaptors. Libraries were evaluated using a BioAnalyzer (Agilent), and quantified by qPCR (Kappa) and PicoGreen.
Libraries were sequenced on the Illumina HiSeq X Ten with v1 chemistry. Sequencing libraries were pooled in equimolar amounts (8 samples/pool), and 2.5 or 3 nM pooled library was loaded onto each lane of the patterned flow cell, and clustered on a cBot (Illumina). Each pool of libraries was sequenced on eight lanes of a flow cell. The HiSeq X generates ~ 375 to 400 M pass filter 2 × 150 bp reads per flow cell lane. For samples that did not meet 30× mean genome coverage post alignment, additional aliquots of the sequencing libraries were pooled in proportion to the amount of additional reads needed, and re-sequenced in one or more flow cell lanes.
Upon completion of sequencing run, bcl files were demultiplexed and quality of sequencing data reviewed using SAV software (Illumina) and FastQC (downloaded from http:// www.bioin forma tics.babra ham.ac.uk/proje cts/fastq c/) for deviations from expected values with respect to total number of reads, percent reads demultiplexed (> 95%), percent clusters pass filter (> 55%), base quality by lane and cycle, percent bases > Q30 for read 1 and read 2 (> 75%), GC content, and percent N-content. FastQ files were aligned to hg19/GRCh37 using the Burrows-Wheeler Aligner (BWA-MEM v0.78) (Li and Durbin 2009 ) and processed using the best-practices pipeline that includes marking of duplicate reads by the use of Picard tools (v1.83, http://picar d.sourc eforg e.net), realignment around indels, and base recalibration via Genome Analysis Toolkit (GATK v3.2.2) (Van der Auwera et al. 2013) .
Single nucleotide variants were called using GATK HaplotypeCaller, generating a single sample GVCF file. Batches of samples were jointly genotyped using GATK GenotypeGVCFs to generate a multi-sample VCF. Variant Quality Score Recalibration (VQSR) was performed on the multisample VCF, and variants were annotated using VCFtools (Danecek et al. 2011 ) and in-house software.
Sequencing procedures for Complete Genomics, Inc. have been described in our prior publication reporting on a subset of these samples (Carmi et al. 2014 ) using procedures described previously (Drmanac et al. 2010; Roach et al. 2010) . The average raw sequencing depth was 56×. The first 58 genomes were called using CG pipeline 2.0.2.26. All other genomes were called using pipeline 2.0.4.14. Both pipelines mapped variants to reference genome version hg19/GRCh37.
QC pipeline: rationale
In developing our AJ reference panel, we sought to maximize the amount of information obtainable from each sample, by employing full-depth sequencing as well as a quality control pipeline that attempted to optimize the tradeoff between sensitivity (avoidance of false negative variant calls) and specificity (avoidance of false positive calls). To date, most QC pipelines for full-depth next-generation sequencing have sought to identify causal variants for unusual phenotypes, thus prioritizing the minimization of false positives, at times sacrificing regions of the genome that are more difficult to call. Similarly, recent consensus efforts to create "gold standard" reference calls tend to be limited to the most readily sequenced portions of the genome (Zook et al. 2014 (Zook et al. , 2016 . For example, it is widely acknowledged that low complexity regions (LCR), including homopolymers, short tandem repeats, and other repetitive elements comprise ~ 2% of the genome and are relatively inaccessible to accurate sequencing from short-read technologies (Li 2014) .
Additionally, the 1000 Genomes Project divided the genomic space into three compartments (strict, pilot, and masked) based on observed read depth and mapping quality scores (1000 Genomes Project Consortium 2015 . Only 77% of the genome was included in the 'strict' (highest-quality) compartment, defined as those regions in which local depth of coverage remained within 50% of the genome-wide average depth, and no more than 0.1% of reads have mapping quality of zero. By contrast, 4% of the genome demonstrated extremes of coverage (high and low) and contained many (> 20%) low-quality reads, and was therefore considered 'masked.' The remaining 'pilot' regions (19% of the genome) remained of questionable quality.
In the present manuscript, we describe steps that greatly decrease false positives and substantially increase the fraction of the genome that is confidently called. Additionally, because our reference panel was sequenced on two disparate platforms (Complete Genomics, Inc. (CGI) and Illumina Hiseq X Ten, see Supplementary Fig. 1 ), we describe an approach to reconcile data across platforms, extending previous work on this problem by including a larger number of replicate samples than previously described (Lam et al. 2011; Ross et al. 2013; Rieber et al. 2013; Wall et al. 2014 ). Finally, we identify new regions across the genome that are not currently well-mapped on either reference or alternate scaffolds, but which are routinely generated on the newest whole genome platforms, extending recent work on so-called blacklisted regions of the genome (Miga et al. 2015) .
Platform-specific filtering
The sensitivity-specificity tradeoff in detecting variants is a key step in large-scale sequencing efforts, often requiring dataset-specific adjustments. To examine false-positive rates, Mendelian errors for a trio included in the Illuminasequenced batch were examined as a function of VQSLOD score and genomic compartment. Since the de novo mutation rate is ~ 1.6 × 10 −8 per base pair per generation (Lipson et al. 2015; Palamara et al. 2015) , this was considered negligible relative to the potential error rate. Additionally, we applied a genotype quality (GQ) filter of 20, and call rate threshold of > 90%, as variants below these thresholds were greatly over-represented in the masked and LCR regions.
Cross-platform filtering
We filtered out ~ 5 K SNVs with observed allele frequencies of > 20% in the CGI dataset that were not observed at all in the larger Illumina dataset, as well as ~ 39 K Illumina SNVs with allele frequency > 20% that were not observed 1 3 in either the CGI dataset or the 1000 Genomes database. We also filtered out 916 SNVs which were called in both CGI and Illumina but had an allele frequency difference larger than 20 percentage points, and an additional 483 K SNPs not called in either Illumina batch or the HRC but contributes to majority of the imputation errors (Supplementary Table 2 ). We also filtered out SNP and INDELs past the Hardy-Weinberg threshold (p < 10 −10 ) in at least one platform, following the site filtering method used in constructing the HRC panel (McCarthy et al. 2016) . Any multi-allelic variants (Campbell et al. 2016) were also excluded after merging Illumina and CGI call sets before constructing the AJ reference imputation panel.
Imputation evaluation
We considered the accuracy of imputation with our population-specific reference panel by comparing it to large, cosmopolitan reference panels in three ways. For each of these analyses, the non-reference discrepancy (NRD), both overall and for each genotype category [i.e., each of the possible combinations of reference (R) and alternate (A) alleles], were defined as below:
2 is the coefficient of determination between imputed genotype dosage and the external standard of all evaluated samples • the aggregated R 2 is calculated on each SNP and then averaged over all SNPs of each bin.
First, we examined imputation of common (non-reference allele frequencies > 5%) and infrequent variants (non-reference allele frequencies > 1% but < 5%) utilizing an independent test cohort of AJ subjects (n = 2195, after removing 349 subjects overlapping with the sequencing cohort) with high-quality genotypes available at ~ 1 M SNPs assayed using the Illumina Omni-Quad platform, as described previously (Lencz et al. 2013) . (Of course, it should be noted that some small percentage of genotyping errors exist in the array data.) A random subset of variants in the array data that were spread across the frequency spectrum were masked and held out to test concordance of imputed vs. masked genotypes. Specifically, we randomly masked and compared 30 SNP sites for each of the following allele frequency (AF) bins: 1-2, 2-5, 5-10, 10-20, 20-50 and 50-100%. Thus, the number of genotypes used for evaluation for each bin is 30 × 2195 = 65,850 per bin. Imputation was performed either locally, using SHAPEIT2 and Impute2, or using the HRC imputation server at Sanger (using SHAPEIT2 for prephasing and PBWT for imputation). Then genotype discordance and aggregated R 2 were calculated respectively using the SNP array genotypes as the gold standard on chromosome 20.
Second, we evaluated the imputation accuracy of all the sites available on both the constructed AJ panel and the HRC panel on chromosome 20, which represents a wider allele frequency spectrum than the SNP array comparison. The genotypes of 36 AJ individuals sequenced by CGI were used as a hold-out sample to calculate the non-reference genotype discordance vs. the allele frequency. Notably, we also evaluated the imputed genotypes on variants private to the AJ panel (i.e., not called in the HRC panel) and found the overwhelming majority of false-positive imputation errors were drawn from variants that were observed exclusively in the CGI samples but not supported by the larger set of Illumina-sequenced samples of the AJ reference panel. Consequently, as a final step in construction and cleaning of the AJ reference panel, we eliminated all such variants exclusive to the CGI samples.
Last, we evaluated the imputation accuracy of the rarest variants in AJ panel, most of which are private in AJ population. To control the sequencing error at the minimum level, we evaluated all the variants with a non-reference allele count from 2 to 5 in Illumina sequencing samples 
Evaluation of variant filtering in personal genomes
We employed a leave-one-out approach, where we examined novel (i.e., not in dbSNP147) variants in each individual sample in relation to the remaining samples in the reference panel. In a clinical context, such variants may be labeled variants of uncertain significance (VUS).
Results
Enhancing call accuracy
After applying platform-specific filtering (see "Materials and methods"), Mendelian errors in the Illumina-sequenced trio were reduced by nearly two orders of magnitude in both the pilot and strict non-LCR regions (Table 1a , cells marked in bold). Using default output from GATK (i.e., prior to our custom VQSLOD filtering), Mendelian error rates for single nucleotide variants (SNVs) were moderate (0.17%) in the strict, non-LCR region; however, across millions of variant sites, such a rate still implies several thousand false positives. Moreover, error rates were unacceptably high in all other compartments (Table 1a) . Mendelian errors were reduced as VQSLOD filtering was increased, though in a non-linear fashion. As shown in Fig. 1, a plateau was reached at VQSLOD = −2 for calls in the pilot region (red) and VQSLOD = −2.5 in the strict (blue) regions.
The relationship between errors and VQSLOD was different for indels, such that no plateau was observed; true and false positives were intermingled across the quality spectrum (Supplementary Fig. 2 ). Consequently, we utilized a VQSLOD = 0 threshold, which resulted in a 1% Mendelian error rate for indels in the pilot and strict (non-LCR) compartments. When combined with GQ and call rate thresholds as above, filtering resulted in an acceptable Mendelian error rate (Table 1b) . For both SNVs and indels, no usable relationships were observed between VQSLOD and error rates in LCR regions, or in the masked compartment, so variants in these regions (~ 6% of the whole genome) were excluded from further analyses. CGI samples (n = 168) were called individually using a proprietary pipeline from Complete Genomics, Inc.; similar quality metrics were therefore not available. (It should be noted that n = 36 of these CGI samples were held out for subsequent testing of the accuracy of the imputation reference panel.) False positives were identified by examination of nine samples run on both platforms, using Illumina data as the gold standard. Initial analysis of CGI data demonstrated that 7.99% of SNV calls were not observed in the Illumina calls for the same individuals. However, more than half (51.2%) of these false positives were observed to be singletons in the full CGI dataset. Consequently, we applied the following filters to the CGI data: (1) remove singletons; (2) remove masked and LCR regions; (3) remove variants called in < 90% of CGI samples. Of the resulting SNVs calls, 97.2% were validated in the filtered Illumina data. Similar results were obtained in the CGI indel data; after applying the same filtering pipeline, however, only 91.5% were validated in the filtered Illumina data. Consequently, any indels which were only observed on the CGI platform (and never in the Illumina dataset) were filtered out.
Cross-platform merging
In total, we observed 17.6 M variants in the filtered Illumina dataset, and around a half (~ 8.8 M) of these in the smaller CGI dataset. Among the SNVs called in both Illumina and CGI data, virtually all (99.99%) had consistent allele frequencies across platform. Only 916 SNPs had allele frequency differences > 20 percentage points ( Supplementary  Fig. 3 ), which would correspond to > 6 standard deviations for a randomly sampled common variant. Outlying frequencies of Illumina variants that were inconsistent with their CGI frequencies were often small-integer fractions, suggestive of copy-number variants and motivating cross platform filtering (see "Materials and methods", and Supplementary Table 2 , first three rows).
Notably, we found that high-frequency Illumina-only SNVs that were not observed in the 1000 Genomes database tended to cluster within specific chromosomal intervals, often (but not always) near the telomeres and centromeres ( Supplementary Fig. 4 ). One such region is displayed in Fig. 2 ; in the top panel, a lengthy stretch of uncatalogued variants is observed in a 25 kb segment within the gene Fig. 2 The utility of mapping to multiple reference sequences. Readbrowser results of mapping for a 25 kb segment along chromosome 17. Color identifies supposedly identified novel variants. The four panels from the top to bottom depict: (1) mapping against standard hg19/GRCh37 reference; (2) mapping against hg19/GRCh37 + "sponge" sequence of Miga et al. (2015) ; (3) mapping against hg19/ GRCh37 + decoy sequences derived from the 1000 Genomes Project; (4) mapping against hg19/GRCh37 + sponge sequence + decoy sequence. Note that the two additional sets of reference sequences remove likely false-positive variants in different regions and combining them together could remove the most. (Colour figure online) MAP2K3, near the chromosome 17 centromere. As shown in the lower panels, mapping against the alternate "sponge sequence" developed by Miga et al. (2015) and the "decoy" sequence proposed by the 1000 Genomes Consortium (2015) re-assigns these reads, such that these variants are no longer mapped within this gene sequence. However, not all such regions were completely cleared using either of these published alternative scaffolds, or using the hg38 alignment. We identified 90 regions that harbor high-frequency, uncatalogued runs of variants as listed in Supplementary Table 3 . We compared these regions to the segmental duplication bed file defined by the Global Alliance for Genomic Health (GA4GH, Lawler et al. 2015) . Only 19% of the regions observed in current data set have at least 50% overlapping bases with the GA4GH segmental duplication bed file, and only 30% of the 90 mis-mapped regions overlap at least 20% with the GA4GH file. Thus, a large portion of mis-mapped regions still cannot be well characterized, probably due to population specific duplications and other events.
Copy-number variation is a plausible source of these anomalies, given that these regions are marked by individuals carrying derived alleles, called heterozygous at multiple neighboring positions. However, the boundaries of these regions do not precisely track boundaries of known copynumber variants in DGV. For purposes of developing the imputation reference, SNPs in these regions were filtered using a loose Hardy-Weinberg threshold (p < 10 −10 ), consistent with the site filtering method used in constructing the HRC panel (McCarthy et al. 2016) , yielding a final set of 17.5 M SNVs in our combined reference dataset (total N = 738).
Imputation performance
We compared the contribution of our newly constructed population-specific reference panel to the accuracy of imputing common and infrequent alleles in our sample of n = 2195 Ashkenazi subjects genotyped on the Omni-Quad chip array (see "Materials and methods"). As shown in Table 2 , we observe discordance rates to be nearly an order of magnitude smaller when using the Ashkenazi reference sequences as compared to the cosmopolitan 1000 Genomes panel and the European-specific UK10K panel. Performance of the AJ panel is ~ twofold better than the cosmopolitan HRC panel, despite a difference in sample sizes that is two orders of magnitude. Improved performance of the AJ-specific panel is especially meaningful at more rare alleles (Fig. 3) , where imputation using a cosmopolitan panel is often subpar. We observed slight improvement when we combined the AJspecific panel with the 1000 Genomes panel. ; y-axis) across non-reference allele frequencies (x-axis) at held-out SNP-array sites in a genotyped panel of 2195 AJ individuals. Imputation quality is high for common alleles, but rarer ones were imputed markedly better using AJ references samples (AJ only-green, AJ combined with the 1000 genomes, navy blue). (Colour figure online) We also evaluated all overlapping sites between the AJ panel and HRC panel on chromosome 20 using a sample of 36 AJ individuals sequenced on the CGI platform as the hold-out sample ("Materials and methods"). Overall, the non-reference genotype discordance rates of the AJ panel and HRC panel are 0.32 and 0.97%, respectively, which corresponds to a threefold improvement in the AJ panel over the HRC panel (Table 3 , top two rows). This evaluation includes a much larger number of variants and a wider spectrum of allele frequency compared to the SNP array analysis; specifically, the number of available sites for each bin ranged from ~ 200 to ~ 30,000. (The numbers of genotypes are roughly equal to the number of SNP sites multiplied by 36 samples.). The non-reference genotype discordance rates were then plotted vs. allele frequency bins (Fig. 4) . The AJ panel outperformed the HRC panel across all allele frequency bins above 0.145% (i.e., allele count = 2 in the AJ reference panel, Fig. 4 ), despite the HRC panel having a much larger sample size and minimum allele counts of 5 for all the overlapping variants.
Given the biological importance of rare variants, we also evaluated the imputation accuracy of the rarest variants in our constructed AJ panel, which are also most likely to be private in the AJ population and not called in the HRC panel ("Materials and methods"). For variants observed at 0.36% frequency (allele count = 5) in the AJ reference cohort, many individual samples show false positive and negative rates of 0% ( Supplementary Fig. 5, top panel) . Notably, a larger proportion of imputed variants received a no-call in the CGI sequence data, due to its known conservative bias (Lam et al. 2011; Rieber et al. 2013) . Moreover, the overwhelming majority of false-positive imputation calls were drawn from variants that were observed exclusively in the CGI samples of the reference panel, and were not present in the Illuminasequenced samples of the AJ reference panel or in the HRC panel (Table 3 , bottom three rows). Consequently, as a final step in construction and cleaning of the AJ reference panel, we eliminated all such variants exclusive to the CGI samples (Supplementary Table 2 , bottom row). Methods and results for all imputation experiments are summarized in Supplementary Table 4 .
Population-specific variant discovery
Finally, we sought to evaluate the potential utility of the population-specific reference panel as a catalogue of normal variation in the population, applicable to the clinical interpretation of personal genomes (see "Materials and methods"). Filtering against the remaining reference panel removed nearly 80% of novel variants across the entire genome (Fig. 5a ). When considering only novel functional (coding or splicing) variants, the population specific panel improves filtering significantly (p < 1.1 × 10 −10 ), but less dramatically, reducing the median count of such variants from 10 to 8 (Fig. 5b) . Relatedly, we conducted an evaluation of the ability of our reference panel to contribute novel variation relative to the largest available cosmopolitan database, gnomAD. Specifically, we exploited the substantial difference in sample size for exomes relative to whole genomes (~ 8:1) in gnomAD to examine the effects of sampling depth on the utility of adding a new, population-specific panel. By categorizing alleles that were novel to our dataset (i.e., not observed in gnomAD) based on location (exonic vs, non-exonic) and frequency, we observed that novel alleles observed as singletons or doubletons in our panel were observed at similar rates for both exonic and non-exonic positions (approximately 1/650 kb per sample), suggesting that this space is far from saturation even in the well-populated exonic component of gnomAD (nearly 125K samples). Moreover, a number of novel alleles were observed in our dataset at > 1% frequency, although these tended to be more frequently observed in the non-exonic compartment [1.3× more likely to be non-exonic for rare alleles (1-2% frequency) and 2× more likely to be non-exonic for more common alleles (5-10% frequency)]. These results are consistent with the computational estimation that ExAC/gnomAD would be far from saturated even after attaining 500K samples (Zou et al. 2016 ).
Discussion
Our primary results (Tables 1, 3; Figs. 3, 4) demonstrate enhanced accuracy of an imputation panel specific to the AJ population, relative to cosmopolitan panels, especially in the range of infrequent (non-reference allele frequencies > 1% but < 5%) and rare (non-reference allele frequency < 1%) Fig. 4 Non-reference genotype discordance (y-axis) across non-reference allele frequencies (x-axis) at overlapping variant sites between AJ reference panel and HRC reference panel in a sample of 36 AJ individuals sequenced on the CGI platform. Note that the non-reference allele counts/frequencies were calculated in the AJ panel variants that may be most critical to further progress in mapping complex phenotypes (Heinzen et al. 2015; Surakka et al. 2015) . Our results represent a substantial improvement over our prior report (Carmi et al. 2014) , using a much smaller AJ panel (n = 128). In our prior paper, the aggregated R 2 of the rarest bins (1 and 2% allele frequency) were 0.86 and 0.91, respectively (Fig. 2c, Carmi et al. 2014) ; the corresponding result in the present report (Fig. 3) demonstrates R 2 = 0.97 for variants in the 1-2% frequency range. These results also extend prior studies that have shown the superiority of combining population-specific with cosmopolitan panels (Wong et al. 2013; Pistis et al. 2015; Hou et al. 2017; Mitt et al. 2017) , by demonstrating: (1) a moderately sized population-specific reference sample sequenced to full-depth provides better performance than the newlyreleased Haplotype Reference Consortium panel; and (2) addition of a cosmopolitan panel (e.g., 1000 Genomes) to such a population-specific panel provides only marginal improvement in performance, consistent with recent findings in an outbred population cohort (Nagasaki et al. 2015) . As recently demonstrated in non-human species, the greatest predictor of individual imputation accuracy is the genomic relatedness between the target and the reference population (Larmer et al. 2017) . In this context, it should be emphasized that the AJ is an unusual population, marked by a narrow bottleneck and a tradition of endogamy (Atzmon et al. 2010; Palamara et al. 2012) .
Moreover, for clinical purposes of interpreting a personal genome, our population-specific panel significantly enhanced filtering of variants unlikely to be related to disease (Fig. 5) . However, there is still considerable room for additional filtering in the coding regions (Fig. 5b) . As the exome is under greater pressure from negative selection compared to the rest of the genome, it is likely that many exonic variants are of relatively recent origin (i.e., post-dating the bottleneck in AJ history). Given the rapidly expanding nature of the human population in recent centuries (including the post-bottleneck AJ population), exceptionally large samples will be needed to achieve asymptotic representation of background variation (Lohmueller 2014; Zou et al. 2016) . In the applied setting, sequencing of parents may be the most efficient strategy for filtering and variant interpretation (Nagy and Mansukhani 2015) , supplemented by large-scale sequencing resources from the general population ) and moderate-scale population-specific resources such as those described here.
While providing benefits such as those described above, short-read sequencing technologies continue to have technical challenges and limitations that we have sought to address in the present study. While many studies (Highnam et al. 2015; Laehnemann et al. 2016 ) have compared accuracy of different alignment and mapping protocols for raw shortread data, such comparisons are computationally expensive and may be impractical for application to large population cohorts and unavailable in the clinical setting. Many endusers of sequencing data receive batched calls from sequencing centers using standard workflows using the Genome Analysis Toolkit [GATK ( Van der Auwera et al. 2013)] . In this context, the present report provides practical guidelines to filtering for such users (both research and clinical). Our approach yields high accuracy not only for the most stably called regions, but also the so-called "pilot" region, extending high accuracy variant calling to 94% of the genome. This compares favorably to recent approaches such as the Genome in a Bottle (Zook et al. 2014 (Zook et al. , 2016 and ReliableGenome (Popitsch et al. 2017) , which primarily focus on the optimizing accuracy of the ~ 70% of the genome that is least susceptible to technical artifact in short-read data.
The potential clinical importance of expanding the range of the genome that can be called reliably is illustrated in Supplementary Fig. 6 . In this figure, we parse the genes designated by the American College of Medical Genetics and Genomics (ACMG) as harboring clinically actionable variants (Green et al. 2013 ) as a function of proportion of variants observed in each calling compartment (strict/pilot/ masked/LCR) as designated by the 1000 Genomes Project. Each of these genes contains segments that fall in the pilot compartment ( Supplementary Fig. 6a ), and several genes (such as PMS2, SDHC, and SDHD) contain up to 50% of exonic bases designated as pilot ( Supplementary Fig. 6b ). Thus, a clinical readout that is unable to accurately capture these bases would be relatively incomplete.
Several limitations in the short read data were difficult to overcome. For example, while we were able to produce reasonable error rates for indels even within the pilot compartment, these required more careful filtering, and do not have a readily identifiable optimum for balancing false positives vs. false negatives (Supplementary Fig. 2 ). Additionally, we observed that the CGI platform suffers from two significant limitations: it is generally overly conservative (fewer total calls, more non-calls) compared to Illumina, but at the same time it is susceptible to a relatively large number of platform-specific false positives. While this platform is no longer active, legacy datasets should be treated with caution for novel variants, although known variants are conservatively called.Additionally, we have identified regions of the genome that are not well mapped in current reference or alternate assemblies ( Fig. 2; Supplementary Fig. 4 ). Further work is needed to properly characterize the (likely) structural variations that underlie these anomalous segments (Church et al. 2015) .
Finally, we should note that many of our samples were derived from patients with schizophrenia. However, it is unlikely that this fact negatively impacted our imputation results, given that: (1) rare variant enrichment in patients with schizophrenia is < 1 variant per genome (Genovese et al. 2016) ; (2) there is no evidence that disease-associated rare variants have atypical recombination patterns; (3) no existing reference panels screen for disease, and the Haplotype Reference Consortium specifically includes samples derived from large disease cohorts.
